Turkey Finds Chinese Vaccine Efficacy Rate of 91.25% in Trial
- Government says Sinovac shot studied in 3,400-person trial
- Implied efficiency higher than suggested by study in Brazil
This article is for subscribers only.
Turkey said a trial involving thousands of volunteers showed an estimated efficacy rate of 91.25% for a Covid-19 vaccine made by China’s Sinovac Biotech Ltd., a far higher level than suggested in a study of the shot in Brazil.
Since September, Turkey has run trials involving more than 3,400 people, according to a televised news conference by Health Minister Fahrettin Koca. The efficacy rate was determined among roughly half of the participants, he said.